← Evidence map

ReviewCancers2026

VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis.

Elizabeth Nally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis. | OpenQuestion